A new study provides important insight into how amyloid-beta and tau proteins impact brain activity and possibly contribute to cognitive decline in Alzheimer's disease.
Understand Alzheimer's disease Alzheimer's disease is the leading cause of dementia, accounting for approximately 80% of ...
For years, many people with Alzheimer's disease have been diagnosed clinically and confirmed at autopsy. Now Alzheimer's ...
Scientists have developed new potential therapies that selectively remove aggregated tau proteins, which are associated with Alzheimer's disease, and improve symptoms of neurodegeneration in mice.
On Sep. 22, 2024 the St. Joe Frontier Casino and the Alzheimer's Association held their annual Walk to End Alzheimer's.
Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...
Carmen A. Guzman, 75, was reported missing on Sept. 19 when he was last seen with family at Hardee’s restaurant, 913 E. Main ...
There's no single test that can tell when someone has Alzheimer's disease. Identifying the disease in the early stages allows ...
New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...
Optimizing iPSC differentiation significantly improves in vitro Alzheimer's disease models, leading to more accurate and ...
Around 55 million people globally are affected by dementia, with Alzheimer's disease responsible for 70% of these cases. The ...